Related Experiment Video

Updated: Apr 9, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K

Challenges in childhood tuberculosis

S Swaminathan1, G Ramachandran1

  • 1National Institute for Research in Tuberculosis, Chennai, India.

Clinical Pharmacology and Therapeutics
|June 20, 2015
PubMed

Insights

Pediatric tuberculosis (TB) presents differently than in adults, often affecting lymph nodes or spreading throughout the body. Diagnosing and treating children with TB requires specialized approaches due to unique challenges in specimen collection and drug dosing.

Area of Science:

  • Pediatric Infectious Diseases
  • Mycobacterial Infections

Background:

  • Tuberculosis (TB) in children exhibits a distinct disease spectrum compared to adults, encompassing conditions from localized lymphadenitis to disseminated infections.
  • Diagnosing pediatric TB is complicated by difficulties in obtaining respiratory specimens and the frequent extrapulmonary nature of the disease.

Purpose of the Study:

  • To highlight the unique challenges in diagnosing and treating tuberculosis in pediatric populations.
  • To emphasize the need for age- and weight-adjusted drug dosages in pediatric TB treatment.

Main Methods:

  • Review of clinical presentations and diagnostic challenges in pediatric tuberculosis.
  • Analysis of pharmacokinetic and pharmacodynamic considerations for anti-TB drug therapy in children.

Main Results:

  • Pediatric TB manifests with varied clinical presentations, differing significantly from adult respiratory disease.
  • Extrapulmonary TB and difficulties in respiratory specimen collection pose significant diagnostic hurdles in children.
  • Pharmacokinetic and pharmacodynamic variations necessitate tailored drug dosing strategies for pediatric TB patients.

Conclusions:

  • Effective management of pediatric tuberculosis requires addressing specific diagnostic and therapeutic challenges unique to this age group.
  • Adjusting anti-TB drug dosages based on pediatric developmental factors is crucial for optimizing treatment outcomes and minimizing toxicity.

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.4K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.3K

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
903
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
741
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.2K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.5K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
2.0K